Tag Archive for: Seeberger

Draupnir Bio ApS utilises bispecific small molecules to link the lysosomal entry protein Sortilin with specific proteins.Draupnir Bio ApS
Protein degraders

Draupnir Bio ApS raises further equity

Targeted protein degradation Draupnir Bio Aps has raised further €12m in an equitiy investment to advance its preclinical pipeline.

Read more